drugset / Trial / NCT04767828
A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study was to evaluate the progression time and efficacy of brain tumors in patients with brain metastases from HER2-positive breast cancer treated with Pyrrolidine and Capecitabine combined with brain radiotherapy.
Timeline
- Start
- 2020-05-01
- Primary completion
- 2022-06
- Completion
- 2022-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 400 mg | Oral |
| Subject | Capecitabine | Small molecule | 800 mg/m2 | Oral |